Secretion in Vascular Inflammation and Thrombosis
血管炎症和血栓形成中的分泌
基本信息
- 批准号:7278149
- 负责人:
- 金额:$ 27.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-26 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAcuteAffectAlpha GranuleApolipoprotein EArterial Fatty StreakArterial InjuryArteriesArteriosclerosisAtherosclerosisBloodBlood PlateletsBlood VesselsCardiovascular DiseasesCause of DeathCytoplasmic GranulesDataDefectDevelopmentDissectionEnzymesEventHermanski-Pudlak SyndromeHumanInflammatoryInjuryLesionMediatingMolecularMolecular TargetMusMyocardial InfarctionN-ethylmaleimide-sensitive proteinP-SelectinPathway interactionsPharmaceutical PreparationsPlatelet aggregationPlayProcessRab geranylgeranyltransferaseRateRoleRuptureStrokeTNFSF5 geneTestingTherapeuticThrombosisTranslatingVascular remodelingartery occlusioncholesterol biosynthesisin vivoinsightmortalitynovelpreventresearch studytherapeutic targetvascular inflammation
项目摘要
DESCRIPTION (provided by applicant):
Despite recent improvements in mortality, cardiovascular diseases (heart attacks and strokes) remain the leading causes of death. Cardiovascular disease events are triggered by platelet aggregation. Beyond platelet aggregation, there is accumulating evidence that platelet secretion activates pro-thrombotic and pro-inflammatory pathways that cause acute thrombotic occlusion, mediate vascular remodeling and accelerate the atherosclerotic process. Unfortunately, there are no medications available to block the secretory process.
Recently we and others have begun to elucidate the molecular mechanisms of platelet secretion. This proposal seeks to translate these molecular insights into experiments in vivo, that examine the novel hypothesis that platelet secretion could be a therapeutic target for preventing acute thrombotic arterial occlusion, arteriosclerotic vascular remodeling, atherosclerotic plaque rupture and the progression of atherosclerosis. We have selected two key molecular targets in the platelet secretory process. The first target is Rab geranylgeranyltransferase (RabGGTase), an enzyme downstream of the cholesterol biosynthesis pathway, which mediates the formation of platelet alpha granules that secrete pro-thrombotic and pro-inflammatory molecules (e.g., P-selectin, CD40L, etc.). The second target is HPS3p which plays an integral, selective role in the formation of platelet dense granules which contain ADP and other platelet activating molecules. Genetically altered mice deficient in RabGGTase or HPS3p will be used to determine how defects in alpha and/or dense granule secretion affect 1) the release of P-selectin, CD40L and other pro-inflammatory and pro-thrombotic molecules; 2) platelet aggregation; 3) thrombotic occlusion and vascular remodeling following acute vascular injury and, 4) the rates of plaque rupture and the progression of vascular lesions in ApoE-/- atherosclerotic mice. These experiments should define whether targeting these molecules to inhibit the platelet alpha and/or dense granule secretion could be an effective therapeutic strategy for reducing cardiovascular disease.
描述(由申请人提供):
尽管最近死亡率有所改善,但心血管疾病(心脏病发作和中风)仍然是死亡的主要原因。心血管疾病事件由血小板聚集触发。除了血小板聚集,越来越多的证据表明,血小板分泌激活促血栓形成和促炎途径,导致急性血栓闭塞,介导血管重塑和加速动脉粥样硬化过程。 不幸的是,没有药物可以阻止分泌过程。
最近,我们和其他人已经开始阐明血小板分泌的分子机制。该提案旨在将这些分子见解转化为体内实验,研究血小板分泌可能是预防急性血栓性动脉闭塞,动脉粥样硬化血管重塑,动脉粥样硬化斑块破裂和动脉粥样硬化进展的治疗靶点的新假设。我们选择了血小板分泌过程中的两个关键分子靶点。第一个靶标是Rab香叶基香叶基转移酶(RabGGT酶),其是胆固醇生物合成途径下游的酶,其介导血小板α颗粒的形成,所述血小板α颗粒分泌促血栓形成和促炎分子(例如,P-选择素、CD 40 L等)。 第二个靶点是HPS 3 p,它在含有ADP和其他血小板活化分子的血小板致密颗粒的形成中起着不可或缺的选择性作用。RabGGT酶或HPS 3 p缺陷的遗传改变的小鼠将用于确定α和/或致密颗粒分泌缺陷如何影响1)P-选择素、CD 40 L和其它促炎和促血栓形成分子的释放; 2)血小板聚集; 3)急性血管损伤后的血栓性闭塞和血管重塑,4)ApoE-/-动脉粥样硬化小鼠斑块破裂率和血管病变进展。这些实验应该确定靶向这些分子以抑制血小板α和/或致密颗粒分泌是否可能是减少心血管疾病的有效治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guy L Reed其他文献
An unusual case of peripartum cardiomyopathy manifesting with multiple thrombo-embolic phenomena
- DOI:
10.1186/1477-9560-5-18 - 发表时间:
2007-10-29 - 期刊:
- 影响因子:2.200
- 作者:
Uzoma N Ibebuogu;John W Thornton;Guy L Reed - 通讯作者:
Guy L Reed
Guy L Reed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guy L Reed', 18)}}的其他基金
Commercialization Readiness Pilot for Amplifying Fibrinolysis in Ischemic Stroke
放大缺血性中风纤维蛋白溶解的商业化准备试点
- 批准号:
10010350 - 财政年份:2011
- 资助金额:
$ 27.12万 - 项目类别:
Commercialization Readiness Pilot for Amplifying Fibrinolysis in Ischemic Stroke
放大缺血性中风纤维蛋白溶解的商业化准备试点
- 批准号:
10159310 - 财政年份:2011
- 资助金额:
$ 27.12万 - 项目类别:
Secretion in Vascular Inflammation and Thrombosis
血管炎症和血栓形成中的分泌
- 批准号:
6846482 - 财政年份:2004
- 资助金额:
$ 27.12万 - 项目类别:
Secretion in Vascular Inflammation and Thrombosis
血管炎症和血栓形成中的分泌
- 批准号:
6951948 - 财政年份:2004
- 资助金额:
$ 27.12万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 27.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 27.12万 - 项目类别:
Operating Grants